We are live on
!
Find out more
ZVSA
ZyVersa Therapeutics
ZVSA
ZVSA
Delisted
ZVSA was delisted on the 16th of July, 2025.
9 hedge funds and large institutions have $162K invested in ZyVersa Therapeutics in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
120% more capital invested
Capital invested by funds: $73.4K → $162K (+$88.4K)
0.01% more ownership
Funds ownership: 0% → 0.01% (+0.01%)
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
Holders
9
Holders Change
–
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Walleye Capital
New York
|
+$167K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$20.9K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$2.85K |
| 4 |
Millennium Management
New York
|
+$2.56K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.32K |
Top Sellers
| 1 |
VF
Virtu Financial
New York
|
-$30K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$9.7K |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$9.05K |
| 4 |
SG
StoneX Group
New York
|
-$3.12K |
| 5 |
Barclays
London,
United Kingdom
|
-$270 |
